14^th International Conference on Stroke, Neurology and Cerebrovascular Diseases June 20-21, 2023 Amsterdam, Netherlands

Session/Track 1 Neurology and Neurosurgery

Neurology is the branch of medicine that deals with disorders of the nervous system, which include the brain, blood vessels, muscles, and nerves. most areas of neurology are the autonomic, central, and peripheral nervous systems. A physician who works within the field of neurology is named a neurologist. Neurosurgery is surgery of the nervous system. A physician who specializes in neurosurgery. Neurosurgeons aren't just brain surgeons, they're medically trained neurosurgical specialists who also can help patients affected by back and neck pain like some other illnesses starting from trigeminal neuralgia to go injury and paralysis agitans.

Session/Track 2 Stroke and Cerebrovascular Diseases

The common mode of expression of stroke could be a relatively sudden occurrence of a focal neurological deficit. Strokes are broadly categorized as ischemic or hemorrhagic. Ischemic stroke is due to the occlusion of a cerebral blood vessel and causes cerebral infarction. Knowledge of the stroke syndromes, the signs, and symptoms that correspond to the region of the brain that's supplied by each vessel, allows a degree of precision in determining the particular vessel that's occluded, and from the temporal evolution of the syndrome, the underlying explanation for vascular occlusion is often deduced. Cerebrovascular disease refers to a group of conditions, diseases, and disorders that affect the blood vessels and blood supply to the brain. Cerebrovascular disease can develop from a spread of causes, including atherosclerosis, where the arteries become narrow; thrombosis, or embolic blood clot, which may be a grume in an artery of the brain or cerebral phlebothrombosis which may be a blood clot during a vein of the brain.

Session/Track 3 COVID-19 Infection and Neurological Complications

Coronavirus disease-19 (COVID-19) pandemic continues to grow all over the world. Several studies are performed, that specialize in understanding acute respiratory syndrome and treatment strategies. However, there's growing evidence indicating neurological manifestations occur in patients with COVID-19. There are several similarities between neurological complications after SARS-CoV-1, MERS-CoV, and COVID-19, however, the scope of the epidemics and number of patients are very different. Reports on the neurological complications after and through COVID-19 are growing every day. Accordingly, comprehensive knowledge of those complications will help health care providers to be aware of these complications and diagnose and treat them timely.

Session/Track 4 Stroke risk, phenotypes, and death in COVID-19

Stroke is relatively frequent among patients with COVID-19 and has devastating consequences across all ages. The interplay of older age, comorbid conditions, and severity of COVID-19 respiratory symptoms are associated with extremely elevated mortality. Acute cerebrovascular disease, particularly ischemic stroke, has emerged as a serious complication of infection by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiologic agent of the Coronavirus disease‐2019 (COVID-19).

Session/Track 5: Stroke Rehabilitation and Brain Hemorrhage

After hospitalization for stroke, many patients still have problems with physical, speech, and mental functions. Rehabilitation for these problems can be provided in a variety of settings. Rehabilitation programs are critical in helping patients regain lost skills, relearn tasks, and work to be independent again. In many cases, there is great potential for the brain to recover. With diligent rehabilitation, these prospects can get even better. Even if major neurological deficits do not improve, the patient’s functioning can improve as they learn ways to compensate for their problems.

A brain haemorrhage may be a variety of strokes. It's caused by an artery within the brain bursting and causing localized bleeding in the surrounding tissues. This bleeding kills brain cells.  A stroke will cause lasting brain injury. people who survive a stroke have to be compelled to acquire skills they lost because of the injury. Rehabilitation will help them acquire those skills.

• The effects of a stroke depend on the area of the brain that was damaged. the categories of disabilities a stroke can cause include
• paralysis or problems controlling movement
• Pain and alternative issues with the senses
• problems using or understanding language
• problems with thinking and memory
• Emotional disturbances

Session/Track 6: Ischemic Stroke and Transient Ischemic Attack

Ischemic stroke occurs when an artery to the brain is blocked.  The brain depends on its arteries to bring contemporary blood from the heart and lungs. The blood carries oxygen and nutrients to the brain and takes away carbon dioxide and cellular waste. If an artery is blocked, the brain cells cannot create enough energy and can eventually stop working. A transient ischemic attack may be a stroke that lasts only some minutes. It happens once the blood supply to a part of the brain is briefly blocked. Symptoms of a transient ischemic attack are like alternative stroke symptoms, however, don't last as long. They happen suddenly and include

• Numbness or weakness, especially on one side of the body
• Confusion or trouble speaking or understanding speech
• Trouble seeing in one or both eyes
• Difficulty walking
• Dizziness
• Loss of balance or coordination

Session/Track 7: Cryptogenic Stroke and Antiplatelet Therapy

In most cases, a stroke is caused by a blood clot that blocks blood flow to the brain. However in some instances, despite testing, the cause can’t be determined. Strokes while not a known cause is referred to as cryptogenic. That’s why it’s necessary to dig deeper for a definitive diagnosis. Collaboration by neurologists, cardiologists, electrophysiologists, and others might reveal the answers required to supply the targeted treatment for preventing recurrent strokes. Antiplatelets are a bunch of medicines that stop blood cells from sticking together and forming a blood clot. Whenever there's an injury in your body, platelets are sent to the site of the injury, wherever they clump along to make a blood clot. This stops the bleeding in your body.

Patients are usually given antiplatelets if they have a history of

• Coronary artery disease (CAD)
• Heart attack
• Angina
• Stroke or transient ischemic attacks (TIAs)
• Peripheral vascular disease (PVD)

Session/Track 8: Risk factors, Diagnosis, Medications, and Recovery

History could include asking about what symptoms are present, once they began, and if they're rising, progressing, or remaining similar. Past medical history can look for stroke risk factors, medications, allergies, and any recent sicknesses or surgeries. Medication history is extremely necessary, particularly when the patient is taking anticoagulants warfarin, dabigatran, rivaroxaban, apixaban, enoxaparin. Physical examination includes assessing vital signs and patient wakefulness. A neurological examination is performed, typically using the standardized stroke scale. Heart, lungs, and abdomen are also assessed. specialized stroke centres -- hospitals that have the doctors, equipment, and resources to intervene quickly and treat strokes aggressively -- have shown to increase stroke survival similarly to patient function and recovery.

Session/Track 9: Cardiovascular and Stroke Nursing

Cardiovascular disease may be a category of disease that involve the heart or blood vessels. CVD includes coronary artery diseases like angina and myocardial infarction different CVDs include stroke, heart failure, hypertensive heart condition, rheumatic heart condition, cardiomyopathy, abnormal heart rhythms, congenital heart condition, valvular heart condition, carditis, aortic aneurysms, peripheral artery sickness, thromboembolic sickness, and thrombosis.

• Physiological monitoring and maintenance of homeostasis
• Reduce morbidity and prevent mortality
• Prevent and observe lesion extension and cerebral oedema
• Prevent complications
• Understand stroke aetiology
• Assess potential/ Facilitate recovery
• Multi-disciplinary assessment and input
• Prevent recurrent stroke

Session/Track 10: Heart Failure and Heart Diseases

Heart failure, generally called congestive heart failure, happens once your muscle doesn't pump blood likewise as a result of it ought to. certain conditions, like narrowed arteries in your heart or high force per unit area, gradually leave your heart too weak or stiff to fill and pump efficiently. cardiopathy describes a range of conditions that have an impact on your heart. Diseases under the heart disease umbrella include blood vessel diseases, like coronary artery disease; heart rhythm problems, and heart defects you're born with, among others. Shortness of breath once you exert yourself or when you lie down

• Fatigue and weakness
• Swelling in your legs, ankles, and feet
• Chest pain, chest tightness, chest pressure, and chest discomfort
• Shortness of breath
• Pain, numbness, weakness, or coldness in your legs or arms if the blood vessels in those components of your body are narrowed
• Pain within the neck, jaw, throat, upper abdomen, or back

Session/Track 11: Cardiac Arrest and Recovery

A cardiac arrest usually happens without warning. If somebody is in cardiac arrest, they collapse suddenly and will be unconscious, unresponsive, and won't be respiration or breathing ordinarily - not breathing normally could mean they’re making gasping noises. Immediate recovery: when a cardiac arrest, you’ll are taken care of in a coronary care or medical aid unit. you may have been put in an associate-induced coma and kept asleep to permit your body to recover. Mid-term recovery: Doctors and cardiologists can need to figure out what caused the cardiac arrest. they will then recommend medication and treatment, such as a pacemaker or implantable cardioverter electronic device (ICD), to reduce the risk of it happening once more. long recovery: it'll take time to recover when a cardiac arrest, however, your doctor can support you throughout now. seek advice from family and doctors regarding what's going to happen once you go back and sensible matters, like driving.

Session/Track 12 Geriatric Cardiology and Palliative Care

The geriatric cardiologist involves see the cardiovascular system from a perspective of an associated ageing body that's probably to be frail, noncompliance, disorganized, and confused, experiencing impaired operation of many organ systems, and damage from earlier diseases. Poor lifestyle choices, inadequate preventive health habits, consuming a good sort of frequently prescribed medications and in a situation wherever the parsimony of science now not applies, the prevalence of systolic and diastolic heart disease, cardiac arrhythmia, aortic stenosis, and electrical conduction defects will increase with age, leading to a major burden of cardiovascular disease. Palliative care is specialized medical care for people living with a serious health problem, this kind of care is concentrated on providing relief from the symptoms and stress of the health problem. The goal is to enhance the standard of life for each patient and the family. Palliative care is based on the needs of the patient, not on the patient’s prognosis. Its right at any age and any stage in a serious health problem, and it are provided along with curative treatment.

Session/Track 13: Cardiac Nursing and Health Care

Cardiac nursing could be a speciality focused on preventing and treating conditions associated with the heart. Like alternative nursing specialities, a profession in cardiac nursing needs an understanding of normal cardiac anatomy and physiology, keen assessment and observance skills, vast information on cardiac disease and conditions, and in-progress education associated with counselled interference strategies and treatment options. Cardiac nurses may work in inpatient or outpatient settings, care for medical or surgical patients, and see patients through acute illness or help them manage chronic illness.

Session/Track 14: Hypertension and Cardiovascular Research

Hypertension is often referred to as the silent killer as there aren't any directly visible symptoms that occur in patients. In several cases, the diagnosis is made only if alternative medical conditions associated with the heart, arteries, kidneys, or brain crop up. It’s thus essential to realize detailed info concerning hypertension and its types. Even as there aren't any symptoms, the causes of high blood pressure are unknown in virtually 90% of the cases. Factors like family history of high BP, age, gender, obesity, smoking, drinking, and an inactive mode among others are possible reasons for developing high blood pressure although they continue to be inconclusive. Cardiovascular is elating to the circulatory system, which includes the centre and blood vessels and carries nutrients and oxygen to the tissues of the body and removes carbon dioxide and alternative wastes from them. Cardiovascular diseases are conditions that have an effect on the heart and blood vessels and include hardening of the arteries, artery illness, heart valve illness, arrhythmia, heart failure, high blood pressure, hypotension, shock, endocarditis, diseases of the artery and its branches, disorders of the peripheral vascular system, and congenital heart disease.

Session/Track 15: Neurophysiology and Neurodegeneration

Neurophysiology is broadly defined because of the study of nervous system function. In this field, scientists investigate the central and peripheral nervous systems at the extent of whole organs, cellular networks, single cells, or maybe subcellular compartments. A unifying feature of this wide-ranging discipline is an interest within the mechanisms that cause the generation and propagation of electrical impulses within and between neurons. This subject is vital not just for our understanding of the fascinating processes driving human thought but also for our ability to diagnose and treat disorders associated with nervous system malfunction. Neurodegeneration may be a complex multifactorial process that causes neuronal death within the brain and spinal cord, leading to brain and spinal cord damage and dysfunction.

• Alzheimer's disease
• Amyotrophic lateral sclerosis
• Friedreich's ataxia
• Huntington's disease
• Lewy body disease
• Parkinson's disease
• Spinal muscular atrophy

Session/Track 16: Neurological Disorders and Neuroplasticity

Neurological disorders are diseases of the central and peripheral nervous systems. In alternative words, the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscles. These disorders embody epilepsy, Alzheimer's sickness, and alternative dementias, vessel diseases also as stroke, migraine, and alternative headache disorders, multiple sclerosis, Parkinson's illness, neuro infections, brain tumours, traumatic disorders of the systema nervosum due to head trauma, and neurological disorders as a result of malnutrition. Neuroplasticity is that the brain's ability to reorganize itself by forming new neural connections throughout life. Neuroplasticity permits the neurons within the brain to catch up on injury and illness and to manage their activities in response to new situations or changes in their environment.

Session/Track 17: Biomarkers and Clinical Research

A biomarker shows a biological molecule or gene this is used to efficiently and correctly examine pharmacologic responses, pathogenic procedures, and organic procedures. Also known as a molecular marker or signature molecule, biomarkers are detected in blood, other body fluids, and tissue. The global marketplace for biomarkers is gaining traction from several factors, along with prevalence and prognosis of life-threatening diseases like cancer, cardiovascular diseases, neurological disorders, etc., that's, in turn, raising the attention and growing the call for early prognosis, reducing the value of medical trials in numerous emerging economies, growing investment in studies and improvement via biotechnology and pharmaceutical companies, and new initiatives approximately biomarker research. On the other hand, the biomarkers market is facing challenges from high capital investments, the low price-advantage ratio with total investment, and badly suited regulatory and reimbursement systems.

Session/Track 18: Neuroscience and Neuroimaging

Neuroscience is that the scientific study of the nervous system. It is an interdisciplinary science that combines and draws on multiple fields, from molecules to medicine. Neuroscience is that the study of how the nervous system develops, its structure, and what it does. Neuroscientists specialize in the brain and its impact on behaviour and cognitive functions. Not only is neuroscience concerned with the normal functioning of the nervous system, but also what happens to the nervous system when people have neurological, psychiatric, and neurodevelopmental disorders. Neuroscience is usually mentioned within the plural, as neurosciences. Neuroimaging is the discipline that deals with the in vivo depiction of anatomy and function of the central nervous system (CNS) in health and disease. Neuroimaging encompasses the varied techniques wont to image the structure of the brain, and it is relevant to some health science disciplines, where it's an excellent impact on the understanding, diagnosis, and treatment of neurological diseases.

Session/Track 19: Alzheimer’s Disease and Dementia

Dementia and Alzheimer’s disease aren’t equivalent. Dementia is an overall term used to describe symptoms that impact memory, the performance of daily activities, and communication abilities. Alzheimer’s disease is that the most common sort of dementia. Alzheimer’s disease gets worse with time and affects memory, language, and thought. While younger people can develop dementia or Alzheimer’s disease, your risk increases as you age. Still, neither is considered a normal part of ageing. Although symptoms of the two conditions may overlap, distinguishing them is vital for management and treatment. Dementia may be a syndrome, not a disease. A syndrome may be a group of symptoms that doesn’t have a definitive diagnosis. Dementia may be a group of symptoms that affects mental cognitive tasks like memory and reasoning. Dementia is that the term applied to a group of symptoms that negatively impact memory, but Alzheimer’s may be a progressive disease of the brain that slowly causes impairment in memory and cognitive function. the exact cause is unknown and no cure is out there.

We are pleased to invite you to the 14th International Conference on Stroke, Neurology and Cerebrovascular Diseases (Stroke Meeting 2023) to be held in Amsterdam, Netherlands June 20-21, 2023. Stroke Meeting 2023 will be a gathering of neurology researchers, scholars, academicians, practitioners, delegates, students and business personnel to present all the updates in neuroscience. Join us to learn, share and listen to the experts about their recent outcomes and their future expectation.

Learn and share through Workshops and Interactive Sessions: 

Workshops and interactive sessions involve extensive interaction between the presenters and delegates around an idea or hands-on experience of a practice. These interactive sessions may take the form of a panel, staged conversation or debate – all involving substantial interaction with the participants. Therefore a variety of sessions, keynote lectures, symposiums, workshops and poster presentations will allow you to share and present research to your colleagues from around the world. 

Meet your subject matter experts: 

Subject Matter Experts will lead you in current research & development. They help you with research queries, and content, identify the objectives, and ensure your research is scientifically acceptably.

Stroke Meeting 2023 has its specially designed networking and round table discussion session, which brings together the clinicians, health professionals, and patients on the front lines of neurology to learn from each other and build professional networks and collaboration. 

Neuroscience defines the systematic study of the mechanics of the central nervous system such as its structure, function, physiology, and genetics including by what means this can be related to understanding diseases of the nervous system whereas ‘Neurology’ is the branch of medicine that is concerned with diseases and disorders of the nervous system ranging from Alzheimer's disease, epilepsy, dementia & stroke, migraine respectively including neuroinfectious and brain tumours. Neurology includes diagnosing and treating conditions of the central, peripheral and autonomic nervous systems. 

The field of neurology includes a broad range of subspecialties few of them are child neurology, clinical neurophysiology, endovascular surgical neuroradiology, hospice & palliative medicine, neuromuscular medicine, sleep medicine, pain medicine, vascular neurology, autonomic disorders, behavioural neurology & neuropsychiatry, geriatric neurology, neural repair & rehabilitation medicine, neuroimaging, neuro-oncology, psychosomatic medicine, neurosurgery. 

Neuroscience Conferences organizes about 3000+ global events including international conferences, symposia, trade shows, workshops, exhibitions and science congresses in all the major scientific disciplines, including medical, pharmaceutical, technology, clinical, engineering, and business management & life sciences globally. Conference Series is conducting several. 

Neuroscience/Psychiatric/Stroke events globally focus primarily on neurology, neurosurgery, neuro-oncology, and neuroimaging. These neurology conferences witness researchers, academic professors, pharmacists, physicians & surgeons who endeavour to disseminate their research experience to escalate the forthcoming research ideas. 

Global Neurology Market embraces many therapeutics used for the treatment of several neurological disorders. The novel pipeline, patent expiry of blockbuster drug and new drug approval has affected the neurology market and it is estimated to grow through the forecast period. The biopharmaceutical companies are investing substantially in the development of advanced therapeutics for the treatment of neurological disorders/diseases. Government organizations are sponsoring research and development activities related to neurology research. These factors are impacting the neurology market positively coupled with the growing prevalence of neurological disorders. The global neurology market is growing due to an increasingly ageing population, expanding awareness regarding mental and neurological illness, increasing health insurance reforms and constant research and development in neurology by pharmaceutical companies. These factors and technological advances such as biomarkers, mobile applications, 3D printed drugs and wearable technologies used to monitor and treat patients diagnosed with neurological disorders are expected to drive the neurology drugs industry.

PRESENTATION REQUIREMENTS:

• Presenting authors are responsible for registration, travel, and hotel costs. Note: Those with accepted abstracts will receive an acceptance mail allowing them to register for the conference.
• Abstracts will be compiled and conference books are made available to participants at the conference.
• Any presenter who is unable to attend should arrange for another qualified individual to present the paper/poster in question. If such a change is necessary, please notify our conference team

SUBMISSION OPTIONS:

• Oral paper presentations will have 30-minute time slots and be clustered by theme into sessions. The keynote session will have a 45-minute time slot, the workshop/ special session will have a 60-minute time slot and the symposium will have a 60-minute time slot followed by a 5-minute Q&A session.
• Graduate & Masters's students are eligible to submit their abstracts under the poster and e-poster presentation category.
• PhD students are eligible to submit their abstract under the special YRF (young researcher’s forum), poster and e-poster presentation category. NOTE: YRF category includes short oral presentations, especially for Ph. D. students
• Extended abstract: Submissions should utilize the Abstract Template. Papers submitted in this category may represent original empirical research, theoretical development, reviews, or critiques.

Oral presentation: Oral Presentations may include the topics from researches, theoretical, professional or private practices in a concise manner. Individuals with personal experience are also welcome to present personal experiences or narratives which help others in everyday life. Speakers with a 30-minute slot should plan to speak for 20-25 minutes, and Keynote speakers should plan to speak for 40-45 minutes, with the remaining time to be used for questions and discussion by the Session Chair.

Workshop: For workshop presenters also, the topic of the talk will be the same as an Oral presentation with more specialized techniques and detailed demonstration. The generalized time duration for a workshop presentation is about 45-50 minutes. Interested participants can join with their respective team and present the workshop with their research coordinators with special group waivers on registration.

Poster presentation: Student Poster Competition will be organized at the Stroke Meeting 2023 conference is to encourage students and recent graduates to present their original research. Presenters will be given about 5-7 minutes to present the poster including questions and answers. Judges may ask questions during the evaluation of the presentation. This is an opportunity for young scientists to learn about the recent findings of their peers to increase their capacity as multidisciplinary researchers. Poster displays will be in hard copy format of 1x1 M long.

For more details regarding Poster Presentation and Judging Criteria view Poster Presentation Guidelines.

Webinar: The webinar presentation is designed for those interested attendees who cannot join in person due to schedule conflicts or other obligations. In this option, the presenter may record the presentation and their presentation will be presented in the Webinar presentation session.

E-Poster: e-Poster is also similar to the webinar presentation. In this session, their presentation will be published in the form of a poster in the conference website and the presenter abstract will be published in the conference souvenir and journal with DOI.

Exhibition: Stroke Meeting 2023 has the opportunity to exhibit the products and services from commercial and non-commercial organizations like Drug manufacturers, Clinical Trial Sites, Management Consultants, Chemists, Pharmacists, Business delegates and Equipment Manufacturers.

To know more about exhibitor booth details and benefits visit WHY TO EXHIBIT WITH US?

Send your queries to stroke@europemeet.net

Advertisement: The conference program is a valuable resource that all attendees refer again and again as they navigate the conference. Advertising in the conference program is a great way to market and can help you secure long term business.

Send your proposal to stroke@europemeet.com to know the available advertisement options and prices

Sponsor Stroke Meeting 2023

Premium Sponsorship package

Additional Sponsorship package

Mail the program manager at stroke@europeanmeets.com  or WhatsApp on (+44 1371 290000 to know more about the sponsorship packages.

Stroke Meeting 2023 organizing committee hereby reiterates that we are NOT authorized to assist with any Visa application works. You may be required to submit a Letter of Invitation, Letter of Abstract Acceptance and Registration Payment Receipt to the embassy. 

Letter of Invitation: A Letter of Invitation is proof that your paper submission and registration application are accepted by the conference committee board. It will be stated in English and may help with your visa application.  

Token Amount: Token amount of USD 150 can be paid and a payment receipt can be proof of payment and may help with your VISA application.   

**SHOULD YOUR APPLICATION BE DENIED, THE STROKE MEETING 2023 ORGANIZING COMMITTEE CAN NOT CHANGE THE DECISION OF THE MINISTRY OF FOREIGN AFFAIRS, NOR WILL WE ENGAGE IN DISCUSSION OR CORRESPONDENCE WITH THE MOFA OR THE EMBASSY ON BEHALF OF THE APPLICANT. THE REGISTRATION FEE WILL BE REFUNDED WHEN THE VISA APPLICATION OF THE INDIVIDUAL IS DENIED AND SHOULD SUBMIT VISA REJECTION PROOF**